| 000 | 01536 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513185222.0 | ||
| 264 | 0 | _c19990901 | |
| 008 | 199909s 0 0 eng d | ||
| 022 | _a1420-4096 | ||
| 024 | 7 |
_a10.1159/000025917 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHuang, S | |
| 245 | 0 | 0 |
_aSuppressed activities of cathepsins and metalloproteinases in the chronic model of puromycin aminonucleoside nephrosis. _h[electronic resource] |
| 260 |
_bKidney & blood pressure research _c1999 |
||
| 300 |
_a121-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntimetabolites, Antineoplastic |
| 650 | 0 | 4 | _aBlood Chemical Analysis |
| 650 | 0 | 4 |
_aCathepsins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 |
_aCollagenases _xmetabolism |
| 650 | 0 | 4 |
_aCreatinine _xblood |
| 650 | 0 | 4 |
_aKidney Glomerulus _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMatrix Metalloproteinase Inhibitors |
| 650 | 0 | 4 |
_aMetalloendopeptidases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNephrosis _xchemically induced |
| 650 | 0 | 4 | _aPuromycin Aminonucleoside |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 700 | 1 | _aSchaefer, R M | |
| 700 | 1 | _aReisch, S | |
| 700 | 1 | _aPaczek, L | |
| 700 | 1 | _aSchaefer, L | |
| 700 | 1 | _aTeschner, M | |
| 700 | 1 | _aSebekova, K | |
| 700 | 1 | _aHeidland, A | |
| 773 | 0 |
_tKidney & blood pressure research _gvol. 22 _gno. 3 _gp. 121-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000025917 _zAvailable from publisher's website |
| 999 |
_c10352399 _d10352399 |
||